COVID-19 and antiphospholipid antibodies

Antiphospholipid syndrome and the coagulopathy of COVID-19 share many pathophysiologic features, including endotheliopathy, hypercoagulability, and activation of platelets, complement pathways, and neutrophil extracellular traps, all acting in concert via a model of immunothrombosis. Antiphospholipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Ayesha, Erkan, Doruk, Lee, Alfred Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568270/
https://www.ncbi.nlm.nih.gov/pubmed/36494152
http://dx.doi.org/10.1016/j.beha.2022.101402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568270/
https://www.ncbi.nlm.nih.gov/pubmed/36494152
http://dx.doi.org/10.1016/j.beha.2022.101402

Ejemplares similares